<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="268">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 08, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00416585</url>
  </required_header>
  <id_info>
    <org_study_id>src-hmnm-1385</org_study_id>
    <nct_id>NCT00416585</nct_id>
  </id_info>
  <brief_title>Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment of Sever Acne</brief_title>
  <official_title>Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti Medical University</source>
  <oversight_info>
    <authority>Iran: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      serum levels Ca, P, PTH and vitamin D metabolites  before and after treatment with
      isotretinoin for sever acne
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      few studies has been done of serum levels Ca, P, PTH and vitamin D metabolites in patients
      receiving  isotretinoin .In this study we measured serum levels Ca, P, PTH and vitamin D
      metabolites before and after treatment with isotretinoin for sever acne in 30 patients . the
      patients had no kown skeletal, endocrine ,renal and gastrointestinal disorders.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date>November 2006</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>serum levels of Ca, P, PTH and vitamin D metabolites and lateral chest x-ray before the treatment</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum levels of Ca, P, PTH and vitamin D metabolites and lateral chest x-ray after the treatment</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Acne</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isotretinoin (Roaccutane)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sever acne

        Exclusion Criteria:

          -  renal disorders

          -  gastrointestinal disorders

          -  skeletal disorders

          -  endocrine disorders

          -  drugs such as glucocorticoids , thiazide diuretics, mineral multivitamins, anti
             acids, tetracyclines
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>parviz toossi, md</last_name>
    <role>Study Chair</role>
    <affiliation>Skin Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hamideh Moravvej, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skin Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nahid Mohtasham, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skin Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shaheed Beheshti Medical University, Skin research center</name>
      <address>
        <city>Tehran</city>
        <zip>198994148</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <lastchanged_date>January 22, 2008</lastchanged_date>
  <firstreceived_date>December 27, 2006</firstreceived_date>
  <keyword>acne</keyword>
  <keyword>isotretinoin</keyword>
  <keyword>calcium. vitamin D</keyword>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Isotretinoin</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
